More than half of people living with HIV and suppressed viral loads nonetheless had imaging-confirmed coronary artery disease — and despite longtime use of HIV
Read more
Home »
Last year, Katherine Gill, MD, an HIV prevention researcher in Cape Town, South Africa, realized how jaded she’d become to vaccine research when the Pfizer
Read more
A 3-month, 12-dose regimen of rifapentine and isoniazid (INH) was less toxic, had better compliance, and showed similar efficacy as 6 months of INH alone
Read more
NEW YORK (Reuters Health) – New research suggests concerns over the concurrent use of bedaquiline and delamanid in patients with drug-resistant tuberculosis were unwarranted. “Prior
Read more